CEO of company of popular weight loss drugs to face Senate questions over high costs in U.S.
Sort by
960 items
-
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.3 days ago -
Financial Times - Business
Deadly flood losses mount as insurers and governments tally costs
Brussels’ pledge of up to €10bn following European floods comes as insurers face estimated €3bn in claims4 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high4 days ago -
CNBC - Business
64% of U.S. retirement savers make this 'dangerous' assumption—'avoid it at all costs,' says CFP
The majority of Americans aren't planning for more than 20 years of retirement. Things could get ugly if they live longer or leave work sooner than expected.4 days ago -
Financial Times - World
FirstFT: Wall Street titan John Paulson defends Trump’s tariff talk
Also in today’s newsletter, S&P 500 hits record high and Amazon’s crackdown on remote work4 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
Financial Times - World
UK government borrows more than expected in August
Net debt hits 100% of GDP in blow to chancellor Rachel Reeves ahead of Budget4 days ago - United Kingdom -
Financial Times - World
Immigration and job creation
The labour market is softer than it appears4 days ago -
Financial Times - World
Lammy seeks emergency boost to aid cash to offset cost of migrant hotels
Foreign secretary fears domestic drain on development funding will hinder efforts to project UK on global stage4 days ago